U.S. Markets open in 7 hrs 19 mins
  • S&P Futures

    3,948.00
    +3.00 (+0.08%)
     
  • Dow Futures

    33,658.00
    +25.00 (+0.07%)
     
  • Nasdaq Futures

    11,575.50
    +9.50 (+0.08%)
     
  • Russell 2000 Futures

    1,814.20
    +0.10 (+0.01%)
     
  • Crude Oil

    74.23
    -0.02 (-0.03%)
     
  • Gold

    1,784.60
    +2.20 (+0.12%)
     
  • Silver

    22.46
    +0.12 (+0.56%)
     
  • EUR/USD

    1.0458
    -0.0011 (-0.1046%)
     
  • 10-Yr Bond

    3.5130
    0.0000 (0.00%)
     
  • Vix

    22.17
    +1.42 (+6.84%)
     
  • GBP/USD

    1.2126
    -0.0007 (-0.0582%)
     
  • USD/JPY

    137.5400
    +0.5800 (+0.4235%)
     
  • BTC-USD

    16,941.06
    -64.75 (-0.38%)
     
  • CMC Crypto 200

    398.96
    -2.84 (-0.71%)
     
  • FTSE 100

    7,521.39
    -46.15 (-0.61%)
     
  • Nikkei 225

    27,686.40
    -199.47 (-0.72%)
     

A Acutus Medical, Inc. (NASDAQ:AFIB) insider increased their holdings by 153% last year

Viewing insider transactions for Acutus Medical, Inc.'s (NASDAQ:AFIB ) over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by insiders in relation to shares sold.

While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.

See our latest analysis for Acutus Medical

Acutus Medical Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider purchase was by insider James Hinrichs for US$151k worth of shares, at about US$3.78 per share. That means that even when the share price was higher than US$0.88 (the recent price), an insider wanted to purchase shares. It's very possible they regret the purchase, but it's more likely they are bullish about the company. In our view, the price an insider pays for shares is very important. Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. James Hinrichs was the only individual insider to buy shares in the last twelve months.

You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

insider-trading-volume
insider-trading-volume

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Insider Ownership Of Acutus Medical

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. We usually like to see fairly high levels of insider ownership. Our data suggests Acutus Medical insiders own 2.9% of the company, worth about US$717k. We prefer to see high levels of insider ownership.

So What Does This Data Suggest About Acutus Medical Insiders?

The fact that there have been no Acutus Medical insider transactions recently certainly doesn't bother us. But insiders have shown more of an appetite for the stock, over the last year. We'd like to see bigger individual holdings. However, we don't see anything to make us think Acutus Medical insiders are doubting the company. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. For instance, we've identified 3 warning signs for Acutus Medical (1 is a bit concerning) you should be aware of.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here